1646TiP Efficacy of SARS-CoV-2 vaccination in cancer patients during treatment: A prospective observational study (ANTICOV trial)

Detalles Bibliográficos
Autores principales: Passalacqua, R., Ratti, M., Pan, A., Testa, S., Molteni, A., Tonoli, S., Faliva, A., Mainardi, E., Saleri, J., Gobbi, A., Nanni, N., Bacciocchini, N., Donati, G., Marchi, R., Cattaneo, M., Gnocchi, N., Grizzi, G., Brighenti, M., Maglietta, G., Caminiti, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454316/
http://dx.doi.org/10.1016/j.annonc.2021.08.1639
_version_ 1784570460604727296
author Passalacqua, R.
Ratti, M.
Pan, A.
Testa, S.
Molteni, A.
Tonoli, S.
Faliva, A.
Mainardi, E.
Saleri, J.
Gobbi, A.
Nanni, N.
Bacciocchini, N.
Donati, G.
Marchi, R.
Cattaneo, M.
Gnocchi, N.
Grizzi, G.
Brighenti, M.
Maglietta, G.
Caminiti, C.
author_facet Passalacqua, R.
Ratti, M.
Pan, A.
Testa, S.
Molteni, A.
Tonoli, S.
Faliva, A.
Mainardi, E.
Saleri, J.
Gobbi, A.
Nanni, N.
Bacciocchini, N.
Donati, G.
Marchi, R.
Cattaneo, M.
Gnocchi, N.
Grizzi, G.
Brighenti, M.
Maglietta, G.
Caminiti, C.
author_sort Passalacqua, R.
collection PubMed
description
format Online
Article
Text
id pubmed-8454316
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-84543162021-09-21 1646TiP Efficacy of SARS-CoV-2 vaccination in cancer patients during treatment: A prospective observational study (ANTICOV trial) Passalacqua, R. Ratti, M. Pan, A. Testa, S. Molteni, A. Tonoli, S. Faliva, A. Mainardi, E. Saleri, J. Gobbi, A. Nanni, N. Bacciocchini, N. Donati, G. Marchi, R. Cattaneo, M. Gnocchi, N. Grizzi, G. Brighenti, M. Maglietta, G. Caminiti, C. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2021-09 2021-09-21 /pmc/articles/PMC8454316/ http://dx.doi.org/10.1016/j.annonc.2021.08.1639 Text en Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Passalacqua, R.
Ratti, M.
Pan, A.
Testa, S.
Molteni, A.
Tonoli, S.
Faliva, A.
Mainardi, E.
Saleri, J.
Gobbi, A.
Nanni, N.
Bacciocchini, N.
Donati, G.
Marchi, R.
Cattaneo, M.
Gnocchi, N.
Grizzi, G.
Brighenti, M.
Maglietta, G.
Caminiti, C.
1646TiP Efficacy of SARS-CoV-2 vaccination in cancer patients during treatment: A prospective observational study (ANTICOV trial)
title 1646TiP Efficacy of SARS-CoV-2 vaccination in cancer patients during treatment: A prospective observational study (ANTICOV trial)
title_full 1646TiP Efficacy of SARS-CoV-2 vaccination in cancer patients during treatment: A prospective observational study (ANTICOV trial)
title_fullStr 1646TiP Efficacy of SARS-CoV-2 vaccination in cancer patients during treatment: A prospective observational study (ANTICOV trial)
title_full_unstemmed 1646TiP Efficacy of SARS-CoV-2 vaccination in cancer patients during treatment: A prospective observational study (ANTICOV trial)
title_short 1646TiP Efficacy of SARS-CoV-2 vaccination in cancer patients during treatment: A prospective observational study (ANTICOV trial)
title_sort 1646tip efficacy of sars-cov-2 vaccination in cancer patients during treatment: a prospective observational study (anticov trial)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454316/
http://dx.doi.org/10.1016/j.annonc.2021.08.1639
work_keys_str_mv AT passalacquar 1646tipefficacyofsarscov2vaccinationincancerpatientsduringtreatmentaprospectiveobservationalstudyanticovtrial
AT rattim 1646tipefficacyofsarscov2vaccinationincancerpatientsduringtreatmentaprospectiveobservationalstudyanticovtrial
AT pana 1646tipefficacyofsarscov2vaccinationincancerpatientsduringtreatmentaprospectiveobservationalstudyanticovtrial
AT testas 1646tipefficacyofsarscov2vaccinationincancerpatientsduringtreatmentaprospectiveobservationalstudyanticovtrial
AT moltenia 1646tipefficacyofsarscov2vaccinationincancerpatientsduringtreatmentaprospectiveobservationalstudyanticovtrial
AT tonolis 1646tipefficacyofsarscov2vaccinationincancerpatientsduringtreatmentaprospectiveobservationalstudyanticovtrial
AT falivaa 1646tipefficacyofsarscov2vaccinationincancerpatientsduringtreatmentaprospectiveobservationalstudyanticovtrial
AT mainardie 1646tipefficacyofsarscov2vaccinationincancerpatientsduringtreatmentaprospectiveobservationalstudyanticovtrial
AT salerij 1646tipefficacyofsarscov2vaccinationincancerpatientsduringtreatmentaprospectiveobservationalstudyanticovtrial
AT gobbia 1646tipefficacyofsarscov2vaccinationincancerpatientsduringtreatmentaprospectiveobservationalstudyanticovtrial
AT nannin 1646tipefficacyofsarscov2vaccinationincancerpatientsduringtreatmentaprospectiveobservationalstudyanticovtrial
AT bacciocchinin 1646tipefficacyofsarscov2vaccinationincancerpatientsduringtreatmentaprospectiveobservationalstudyanticovtrial
AT donatig 1646tipefficacyofsarscov2vaccinationincancerpatientsduringtreatmentaprospectiveobservationalstudyanticovtrial
AT marchir 1646tipefficacyofsarscov2vaccinationincancerpatientsduringtreatmentaprospectiveobservationalstudyanticovtrial
AT cattaneom 1646tipefficacyofsarscov2vaccinationincancerpatientsduringtreatmentaprospectiveobservationalstudyanticovtrial
AT gnocchin 1646tipefficacyofsarscov2vaccinationincancerpatientsduringtreatmentaprospectiveobservationalstudyanticovtrial
AT grizzig 1646tipefficacyofsarscov2vaccinationincancerpatientsduringtreatmentaprospectiveobservationalstudyanticovtrial
AT brighentim 1646tipefficacyofsarscov2vaccinationincancerpatientsduringtreatmentaprospectiveobservationalstudyanticovtrial
AT magliettag 1646tipefficacyofsarscov2vaccinationincancerpatientsduringtreatmentaprospectiveobservationalstudyanticovtrial
AT caminitic 1646tipefficacyofsarscov2vaccinationincancerpatientsduringtreatmentaprospectiveobservationalstudyanticovtrial

Ejemplares similares